Nora BE (Watson Pharma, Inc.)
Welcome to the PulseAid listing for the Nora BE drug offered from Watson Pharma, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Watson Pharma, Inc. |
| NON-PROPRIETARY NAME: | Norethindrone |
| SUBSTANCE NAME: | NORETHINDRONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2005-05-12 |
| END MARKETING DATE: | 0000-00-00 |
Nora BE HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nora BE from Watson Pharma, Inc. |
| LABELER NAME: | Watson Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.35(mg/1) |
| START MARKETING DATE: | 2005-05-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52544-629_cc586725-7f2a-4db4-832d-2f88a35e8d38 |
| PRODUCT NDC: | 52544-629 |
| APPLICATION NUMBER: | NDA017060 |
Other NORETHINDRONE Pharmaceutical Manufacturers / Labelers:
